Sibiliter to Join VivaTech 2026 as Samsung Electronics' Innovative Pet Tech Partner
Sibiliter (CEO Kim Gwanghyun), which operates the AI home care solution “Lifepet” for progressive pet diseases, will participate in VivaTech 2026 as Samsung Electronics’ innovative partner in the pet tech sector.
VivaTech 2026, held in Paris, France, is the largest ICT and startup event in Europe, serving as a key technology exhibition with the participation of numerous global tech companies and innovative startups. Samsung Electronics will showcase its “Connected Care” vision, which integrates artificial intelligence (AI) technology with a unified connected platform ecosystem. Following its presence at the world’s largest IT and home appliance exhibition, CES, Sibiliter will introduce its advanced AI-based pet healthcare solution to audiences across Europe at the Samsung Electronics booth at VivaTech.
At this exhibition, Sibiliter will present its AI health analysis solution, officially integrated into Samsung Electronics’ SmartThings Pet Care service. Visitors to the Samsung Electronics booth can experience firsthand the innovative technology that allows them to take photos of their pets with a smartphone and immediately detect signs of oral and ophthalmic abnormalities. The exhibition will feature two services: ▲ AI analysis for pet periodontal disease, and ▲ AI analysis for pet cataract/nuclear sclerosis.
Lifepet’s AI analysis technology applies a proprietary algorithm developed using tens of thousands of clinical data points, delivering high accuracy. In particular, it analyzes and presents the possibility of early-stage diseases that are difficult to visually detect, based on data, allowing pet owners to visit animal hospitals at the appropriate time. This goes beyond simple self-diagnosis and is expected to attract global attention as a diagnostic support tool that contributes to the creation of a healthy medical ecosystem connecting pet owners and veterinarians.
Notably, the ability to detect early signs of major progressive diseases within the ecosystem of everyday smartphones and home appliances—without the need for specialized equipment—demonstrates both mass-market appeal and technological innovation. By building an organic medical system that bridges home care and professional treatment at animal hospitals, this is expected to become a key example of Korean pet tech startups’ leading technological competitiveness within the industry.
Having already obtained animal medical device software approval and established a diverse lineup of diagnostic support solutions, Sibiliter plans to accelerate the expansion of its global B2B partnerships, starting with its participation in VivaTech. The company’s strategy is to become a core technology provider in the global pet tech sector by supplying its validated AI health analysis solutions to global enterprises with pet-related infrastructure, including insurance, commerce, wearables, and smart home appliances.
Kim Gwanghyun, CEO of Sibiliter, stated, “It is meaningful to present the future of pet healthcare at VivaTech, Europe’s premier innovation hub, alongside Samsung Electronics, a global leader in IT, following our participation at CES. We will prove on the global stage that Lifepet’s AI technology can serve as a positive bridge within Samsung Electronics’ tightly connected ecosystem, lowering the barrier for pet owners to visit clinics and supporting veterinarians in their clinical decision-making.”
Hot Picks Today
You Can Receive Monthly Payments Like a Pension Without Selling Your Home... The Local Mutual Growth Housing Pension That Provides 1.69 Million Won Each Month
- "Unimaginable in Korea"...Koreans Surprised by Secondhand Smoke in Japan and China Restaurants
- "Special Skill: Admitting Mistakes"... The Unexpected Edge That Helped Job Seekers Tired of AI Resumes Succeed
- "Canceled After Five Days and Lost 770,000 Won"... Hit by Steep Fees After Pressing the Cancel Button
- "I Thought She Was an Ordinary SKT Employee... The Unexpected Identity of Nongshim's Third-Generation Bride"
Meanwhile, Sibiliter has accumulated unrivaled technological credibility, having first obtained Korea’s initial regulatory approval from the Animal and Plant Quarantine Agency for its “MPL-001 patellar luxation diagnostic support software for dogs” (approval no. 402-001), and more recently, additional approval for its “PDD-001 pet periodontal disease diagnostic support software” (approval no. 402-002). The company plans to further expand its portfolio to include AI analysis solutions for primary skin diseases, aiming to evolve into an all-encompassing digital healthcare platform covering the entire lifecycle of pets.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.